| 000 | 01750 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514041710.0 | ||
| 264 | 0 | _c20020904 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a1465-3249 | ||
| 024 | 7 |
_a10.1080/146532401317070934 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlystad, A K | |
| 245 | 0 | 0 |
_aCD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD. _h[electronic resource] |
| 260 |
_bCytotherapy _c2001 |
||
| 300 |
_a295-305 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntigens, CD34 _ximmunology |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aBone Marrow Cells _ximmunology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Survival _ximmunology |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aHodgkin Disease _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunohistochemistry _xinstrumentation |
| 650 | 0 | 4 |
_aImmunomagnetic Separation _xinstrumentation |
| 650 | 0 | 4 |
_aKi-1 Antigen _ximmunology |
| 650 | 0 | 4 |
_aLymphocytes _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplastic Cells, Circulating _ximmunology |
| 650 | 0 | 4 | _aPlatelet Transfusion |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTorlakovic, E | |
| 700 | 1 | _aHolte, H | |
| 700 | 1 | _aKvaløy, S | |
| 700 | 1 | _aLenschow, E | |
| 700 | 1 | _aKvalheim, G | |
| 773 | 0 |
_tCytotherapy _gvol. 3 _gno. 4 _gp. 295-305 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/146532401317070934 _zAvailable from publisher's website |
| 999 |
_c12054533 _d12054533 |
||